PHASE-II STUDY OF RECOMBINANT ALPHA-INTERFERON AND RECOMBINANT INTERLEUKIN-2 IN METASTATIC BREAST-CANCER

被引：3
|
作者：
WALTERS, RS
THERIAULT, RL
HOLMES, FA
ESPARZA, L
HORTOBAGYI, GN
机构：
[1] Department of Breast and Gynecologic Medical Oncology, Division of Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX
来源：
JOURNAL OF IMMUNOTHERAPY | 1994年 / 16卷 / 04期
关键词：
INTERFERON; INTERLEUKIN-2; METASTATIC BREAST CANCER;
D O I：
10.1097/00002371-199411000-00008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Ten patients with metastatic breast cancer were treated with a combination of recombinant alpha-interferon and recombinant interleukin-2. The toxicity of treatment was considerable, including one death on therapy. No objective responses were seen.
引用
收藏
页码：303 / 305
页数：3
相关论文
共 50 条
  • [41] Phase I trial of subcutaneous recombinant human interleukin-2 in patients with metastatic melanoma
    Eton, O
    Rosenblum, MG
    Legha, SS
    Zhang, WH
    East, MJ
    Bedikian, A
    Papadopoulos, N
    Buzaid, A
    Benjamin, RS
    CANCER, 2002, 95 (01) : 127 - 134
  • [42] DROLOXIFENE IN POSTMENOPAUSAL PATIENTS WITH METASTATIC BREAST-CANCER - DOUBLE-BLIND RANDOMIZED PHASE-II STUDY
    MARSCHNER, N
    KREIENBERG, R
    BALAS, R
    BRANDTNER, M
    SCHLINGENSIEPEN, R
    SCHUMANN, S
    BUTTNER, S
    STAAB, HJ
    RAUSCHNING, W
    ONKOLOGIE, 1994, 17 : 32 - 39
  • [43] PHASE-II STUDY OF CARBOPLATIN AND ETOPOSIDE AS A FIRST-LINE REGIMEN IN PATIENTS WITH METASTATIC BREAST-CANCER
    VANDERGAAST, A
    BONTENBAL, M
    PLANTING, AST
    KOK, TC
    SPLINTER, TAW
    ANNALS OF ONCOLOGY, 1994, 5 (09) : 858 - 860
  • [44] Phase II trial of systemic recombinant interleukin-2 in the treatment of refractory nasopharyngeal carcinoma
    Chi, KH
    Myers, JN
    Chow, KC
    Chan, WK
    Tsang, YW
    Chao, Y
    Yen, SH
    ONCOLOGY, 2001, 60 (02) : 110 - 115
  • [45] Subcutaneous low doses of interleukin-2 and recombinant interferon alpha with carboplatin and vinblastine in patients with advanced melanoma
    Bafaloukos, D
    Fountzilas, G
    Skarlos, D
    Pavlidis, N
    Bakoyiannis, C
    Karvounis, N
    Kosmidis, P
    ONCOLOGY, 1998, 55 (01) : 48 - 52
  • [46] Delirium after interleukin-2 and alpha-interferon therapy for renal cell carcinoma
    Van Steijn, JHM
    Nieboer, P
    Hospers, GAP
    De Vries, EGE
    Mulder, NH
    ANTICANCER RESEARCH, 2001, 21 (05) : 3699 - 3700
  • [47] A phase II study of interferon alpha and low-dose subcutaneous interleukin-2 in advanced renal cell carcinoma
    Piga, A
    Giordani, P
    Quattrone, A
    Giulioni, M
    DeSignoribus, G
    Antognoli, S
    Cellerino, R
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1997, 44 (06) : 348 - 351
  • [48] A PHASE-II STUDY OF DACARBAZINE AND CISPLATIN IN COMBINATION WITH OUTPATIENT ADMINISTERED INTERLEUKIN-2 IN METASTATIC MALIGNANT-MELANOMA
    FLAHERTY, LE
    ROBINSON, W
    REDMAN, BG
    GONZALEZ, R
    MARTINO, S
    KRAUT, M
    VALDIVIESO, M
    RUDOLPH, AR
    CANCER, 1993, 71 (11) : 3520 - 3525
  • [49] PHASE-I STUDY OF SEQUENTIALLY ADMINISTERED RECOMBINANT TUMOR-NECROSIS-FACTOR AND RECOMBINANT INTERLEUKIN-2
    KRIGEL, RL
    PADAVICSHALLER, K
    TOOMEY, C
    COMIS, RL
    WEINER, LM
    JOURNAL OF IMMUNOTHERAPY, 1995, 17 (03): : 161 - 170
  • [50] LOW SERUM LEVELS OF ALPHA-INTERFERON, GAMMA-INTERFERON, AND INTERLEUKIN-2 IN ALCOHOLIC CIRRHOSIS
    VICENTEGUTIERREZ, MM
    RUIZ, AD
    EXTREMERA, BG
    GARCIA, JMB
    GEA, FG
    DIGESTIVE DISEASES AND SCIENCES, 1991, 36 (09) : 1209 - 1212
12345